SparX Group collects over $30m Series B
SparX Group, a Cayman Islands-based immunology company, has raised over $30 million in Series B funding.
SparX Group, a Cayman Islands-based immunology company, has raised over $30 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination